29382 Federal Register / Vol. 87, No. 93 / Friday, May 13, 2022 / Notices 

PORTUGAL, have been added as parties 

to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and Advanced 

Media Workflow Association, Inc. 

intends to file additional written 

notifications disclosing all changes in 

membership. 

On March 28, 2000, Advanced Media 

Workflow Association, Inc. filed its 

original notification pursuant to Section 

6(a) of the Act. The Department of 

Justice published a notice in the Federal 

Register pursuant to Section 6(b) of the 

Act on June 29, 2000 (65 FR 40127). 

The last notification was filed with 

the Department on December 16, 2021. 

A notice was published in the Federal 

Register pursuant to Section 6(b) of the 

Act on January 13, 2022 (87 FR 2181). 

Suzanne Morris, 

Chief, Premerger and Division Statistics, 

Antitrust Division. 

[FR Doc. 2022–10280 Filed 5–12–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—ODVA, Inc. 

Notice is hereby given that, on April 

28, 2022, pursuant to Section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), ODVA, Inc. 

(‘‘ODVA’’) has filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, Sanwa Engineering Corp., 

Hsinchu County, TAIWAN (R.O.C.); 

CMD Corporation, Appleton, WI; JSL 

Technology Co., Ltd., Ashikaga City, 

JAPAN; Nikon Corporation, Tokyo, 

JAPAN; Perinet GmbH, Berlin, 

GERMANY; Panasonic Software 

Development Center Dalian Co., Ltd., 

Dalian, PEOPLE’S REPUBLIC OF 

CHINA; Neurala, Inc., Boston, MA; 

CodeWrights GmbH, Karlsruhe, 

GERMANY; Aber Instruments Ltd, 

Aberystwyth, UNITED KINGDOM; 

Georg Fischer Piping Systems Ltd., 

Schaffhausen, SWITZERLAND; and 

Telsonic AG, Bronschhofen, 

SWITZERLAND, have been added as 

parties to this venture. 

Also, HIMA Paul Hildebrandt GmbH 

& Co KG, Bruehl, GERMANY, has 

withdrawn as a party to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and ODVA 

intends to file additional written 

notifications disclosing all changes in 

membership. 

On June 21, 1995, ODVA filed its 

original notification pursuant to Section 

6(a) of the Act. The Department of 

Justice published a notice in the Federal 

Register pursuant to Section 6(b) of the 

Act on February 15, 1996 (61 FR 6039). 

The last notification was filed with 

the Department on January 4, 2022. A 

notice was published in the Federal 

Register pursuant to Section 6(b) of the 

Act on January 13, 2022 (87 FR 2177). 

Suzanne Morris, 

Chief, Premerger and Division Statistics, 

Antitrust Division. 

[FR Doc. 2022–10281 Filed 5–12–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Medical Technology 

Enterprise Consortium 

Notice is hereby given that, on April 

14, 2022, pursuant to Section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), Medical Technology 

Enterprise Consortium (‘‘MTEC’’) has 

filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, Acenxion Biosystems, Inc., 

Kansas City, KS; Advanced Functional 

Fabrics of America, Inc., Cambridge, 

MA; American Type Culture Collection, 

Manassas, VA; ApnoMed, Inc., 

Bellevue, WA; Arete Associates, 

Northridge, CA; Asayena, La Jolla, CA; 

Aspisafe Solutions, Inc., Brooklyn, NY; 

Atmospheric Plasma Solutions, Cary, 

NC; Avel eCare LLC, Sioux Falls, SD; 

Avocado Labs Inc., Dallas, TX; Baylor 

University, Waco, TX; Bennett Federal 

LLC, Plymouth, MN; Blue Horizon 

Development LLC dba Precise Portions 

LLC, Norfolk, VA; Boston Engineering 

Corporation, Waltham, MA; Cambridge 

Research & Development, Inc., Nashua, 

NH; Capital Edge Consulting, Inc., 

McLean, VA; Caretaker Medical, 

Charlottesville, VA; Centre for Injury 

Studies London, UK; Chenega Reliable 

Services LLC, San Antonio, TX; 

Clemson University Research 

Foundation, Clemson, SC; CorNeat 

Vision Ltd., Raanana, ISR; D-Prime LLC, 

McLean, VA; DxLab, Inc., Somerville, 

MA; Ejenta, Inc., San Francisco, CA; 

Enalare Therapeutics, Inc., Princeton, 

NJ; Excera, Inc., Minneapolis, MN; Fed 

Grow LLC dba FedNetix, Issaquah, WA; 

Federal Strategies LLC, Fredericksburg, 

VA; Frater GmbH, Naters, CH; GelSana 

Therapeutics, Inc., Aurora, CO; HAI 

Solutions, Inc., Santa Barbara, CA; Icahn 

School of Medicine at Mount Sinai, 

New York, NY; Ideal Medical 

Technologies, Inc., Asheville, NC; INdev 

LLC, Austin, TX; JAG Consulting LLC, 

Gulf Breeze, FL; JOHN J. RYAN 

(SEALING PRODUCTS) LIMITED, 

Dunboyne, IRE; Kunasan, Inc., Aurora, 

CO; Lactea Therapeutics LLC, Frederick, 

MD; LAINE Technologies, Goose Creek, 

SC; Leo Mora Therapy Services, PLLC, 

Killeen, TX; Limax Biosciences, Inc., 

Somerville, MA; Matregenix, Irvine, CA; 

MDC Studio, Inc., Baltimore, MD; 

MicroGEM US, Inc., Charlottesville, VA; 

Mid-America Applied Technologies 

Corporation, Chagrin Falls, OH; MLM 

Biologics, Inc., Gainesville, FL; 

Nakamir, Inc., Palo Alto, CA; 

Nanohmics, Inc., Austin, TX; Nanovatif 

Materials Technologies, Ankara, TUR; 

National Association of Veterans’ 

Research and Education Foundations 

(NAVREF), Washington, DC; 

NowSecure, Inc., Vienna, VA; NuPeak 

Therapeutics, St Louis, MO; Obsidio, 

Inc., Columbia, SC; OneBreath, Inc., 

Palo Alto, CA; Organizational 

Performance Systems, Los Altos, CA; 

PALANQUINX PTY LTD, Hornsby 

Heights, AUS; Pascal Medical 

Corporation, Richmond, VA; PCCI, Inc., 

Alexandria, VA; PERSOWN, Inc., 

Jacksonville, FL; Quantumhave Ventura, 

Inc., San Jose, CA; Regranion LLC, Mt. 

Pleasant, SC; Repurposed Therapeutics, 

Inc. dba Defender Pharmaceuticals, Inc., 

Saint Louis, MO; Rock West 

Composites, Inc., San Diego, CA; 

SafetySpect, Inc., Grand Forks, ND; 

SanaHeal, Inc., Boston, MA; Scaled 

Microbiomics LLC, Hagerstown, MD; 

Selsym Biotech, Inc., Raleigh, NC; 

Sherpa 6, Inc., Littleton, CO; SISCAPA 

Assay Technologies, Inc., Washington, 

DC; Soliyarn, Belmont, MA; Sparta 

Biomedical, Inc., Chatham, NJ; SPEAR 

Human Performance, Inc., Sandy 

Springs, GA; SurgiBox, Cambridge, MA; 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 87, No. 93 / Friday, May 13, 2022 / Notices 29383 

TechEn, Inc., Milford, MA; Technion 

Research and Development Foundation 

Ltd, Haifa, ISR; TetraCells, Inc., 

Marietta, GA; The University of Texas at 

Tyler, Tyler, TX; TrainXR LLC, Las 

Vegas, NV; University of Oregon, 

Eugene, OR; University of Texas 

Medical Branch at Galveston, Galveston, 

TX; University of Texas Permian Basin, 

Odessa, TX; University of Texas System, 

Austin, TX; Valtamer Oy, Helsinki, FIN; 

Vista LifeSciences, Inc. dba Vista 

Partners, Parker, CO; Vistendo, Inc., 

Arcadia, CA; War Horses for Veterans, 

Inc., Stilwell, KS; Wave Neuroscience, 

Inc., Newport Beach, CA; and Xomix 

Ltd, Chicago, IL, been added as parties 

to this venture. 

Also, Advancement Strategy LLC, 

Columbia, MD; Aktiv Pharma Group, 

Broomfield, CO; Alcamena Stem Cell 

Therapeutics LLC, Halethorpe, MD; 

Aldyn, Inc., Boston, MA; American 

Systems, Chantilly, VA; Arcos, Inc., 

Missouri City, TX; ARD Global LLC, 

McLean, VA; Avera Health, Sioux Falls, 

SD; Belle Artificial Intelligence 

Corporation, Cambridge, MA; Brainbox 

Solutions, Inc., Richmond, VA; Canvas 

Incorporated, Huntsville, AL; Capricor 

Therapeutics, Inc., Beverly Hills, CA; 

Carahsoft Technology Corporation, 

Reston, VA; Catharsis Productions, 

Chicago, IL; Cimarron Software 

Services, Inc., Houston, TX; Circadian 

Positioning Systems, Inc., Newport, RI; 

Cognosante, Falls Church, VA; 

Computer Technology Associates, Inc., 

Ridgecrest, CA; Dascena, Houston, TX; 

Delta Chase LLC, West Chester, OH; 

Dovel Technologies, McLean, VA; 

Dustoff Technologies LLC, Saint 

Augustine, FL; Exciton Technologies, 

Inc., Edmonton, Alberta, CAN; 

Expesicor, Inc., Missoula, MT; 

Exploration Institute, Cheyenne, WY; 

FesariusTherapeutics, Inc., Brooklyn, 

NY; Florida International University 

Board of Trustees, Miami, FL; FUJIFILM 

Pharmaceuticals USA, Inc., Valhalla, 

NY; GEN–AVIV LLC, North Miami 

Beach, FL; Georgia State University 

Research Foundation, Inc., Atlanta, GA; 

GreyScan, Inc., Melbourne, AUS; iGov 

Technologies, Inc., Tampa, FL; Kurve 

Technology, Inc., Lynnwood, WA; Luna 

Innovations Incorporated, Roanoke, VA; 

Martellus Pty, Ltd., Sydney, AUS; 

Maryland Development Center, 

Baltimore, MD; Navitas Business 

Consulting, Inc., Herndon, VA; Odyssey 

Systems Consulting Group, Ltd., 

Wakefield, MA; Opticyte, Inc., Seattle, 

WA; Parallax Advanced Research 

Corporation, Beavercreek, OH; Parnell 

Pharmaceuticals, Inc., San Rafael, CA; 

Pennsylvania State University, 

University Park, PA; PhAST Corp., 

Cambridge, MA; Phiex Technologies, 

Inc., Boston, MA; Plantiga Technologies, 

Inc., Vancouver, CAN; PreVeteran 

Group LLC, Jackson, WY; Rain 

Technologies LLC, Las Vegas, NV; 

Research Bridge Partners, Inc., Austin, 

TX; Retia Medical LLC, Valhalla, NY; 

Rhode Island Hospital, Providence, RI; 

RIVA Solutions, Inc., Mclean, VA; 

Rockland Technimed Limited, Mahwah, 

NJ; San Diego State University, San 

Diego, CA; SanMelix Laboratories, Inc., 

Hollywood, FL; Sentio Solutions, Inc., 

San Francisco, CA; Seventh Dimension 

LLC, Mocksville, NC; Sibel, Inc., 

Evanston, IL; SweetBio, Inc., Memphis, 

TN; Tagup, Inc., Somerville, MA; ThinkDragon LLC, Ellicott City, MD; Thornton 

Tomasetti, Inc., New York, NY; Throne 

Biotechnologies, Inc., Paramus, NJ; 

TITUS Sports Academy LLC, 

Tallahassee, FL; Turner Innovations, 

Orem, UT; University of New 

Hampshire, Durham, NH; VES LLC, 

Wilmington, OH; Virginia 

Commonwealth University, Richmond, 

VA; W.R. Joyce Incorporated, Michigan 

City, IN; ZIEN Medical Technologies, 

Inc., Salt Lake City, UT, has withdrawn 

as parties to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and MTEC 

intends to file additional written 

notifications disclosing all changes in 

membership. 

On May 9, 2014, MTEC filed its 

original notification pursuant to Section 

6(a) of the Act. The Department of 

Justice published a notice in the Federal 

Register pursuant to Section 6(b) of the 

Act on June 9, 2014 (79 FR 32999). 

The last notification was filed with 

the Department on February 4, 2022. A 

notice was published in the Federal 

Register pursuant to Section 6(b) of the 

Act on March 11, 2022 (87 FR 14041). 

Suzanne Morris, 

Chief, Premerger and Division Statistics, 

Antitrust Division. 

[FR Doc. 2022–10244 Filed 5–12–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Medical CBRN Defense 

Consortium 

Notice is hereby given that, on April 

7, 2022, pursuant to Section 6(a) of the 

National Cooperative Research and 

Production Act of 1993, 15 U.S.C. 4301 

et seq. (‘‘the Act’’), Medical CBRN 

Defense Consortium (‘‘MCDC’’) has filed 

written notifications simultaneously 

with the Attorney General and the 

Federal Trade Commission disclosing 

changes in its membership. The 

notifications were filed for the purpose 

of extending the Act’s provisions 

limiting the recovery of antitrust 

plaintiffs to actual damages under 

specified circumstances. 

Specifically, 7 Hills Pharma LLC, 

Houston, TX; Aleph Therapeutics, Inc., 

Stanford, CA; Amaratek, San Diego, CA; 

Applied Research Associates, Inc.; 

Albuquerque, NM; Horizons Global 

Solutions LLC; Purcellville, VA; Icahn 

School of Medicine at Mount Sinai; 

New York, NY; Iowa State University of 

Science and Technology; Ames, IA; 

Mainstream Engineering Corporation; 

Rockledge, FL; Najit Technologies, Inc.; 

Beaverton, OR; National Strategic 

Research Institute; Lincoln, NE; POP 

Biotechnologies, Inc.; Buffalo, NY; The 

Henry M. Jackson Foundation for the 

Advancement of Military Medicine; 

Bethesda, MD; University of 

Massachusetts; Lowell, MA and Virion 

Therapeutics LLC; Newark, DE have 

been added as parties to this venture. 

Also, Aardvark Medical, Inc., Ross, 

CA; Cytonus Therapeutics, Inc., 

Columbus, OH; Entasis Therapeutics, 

Waltham, MA; EUSA Pharma (US) LLC, 

Burlington, MA; GeneCapture, Inc., 

Huntsville, AL; and Visby Medical, Inc., 

San Jose, CA, have withdrawn as parties 

to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and MCDC 

intends to file additional written 

notifications disclosing all changes in 

membership. 

On November 13, 2015, MCDC filed 

its original notification pursuant to 

Section 6(a) of the Act. The Department 

of Justice published a notice in the 

Federal Register pursuant to Section 

6(b) of the Act on January 6, 2016 (81 

FR 513). 

The last notification was filed with 

the Department on January 10, 2022. A 

notice was published in the Federal 

Register pursuant to Section 6(b) of the 

Act on March 10, 2022 (87 FR 13756). 

Suzanne Morris, 

Chief, Premerger and Division Statistics, 

Antitrust Division. 

[FR Doc. 2022–10239 Filed 5–12–22; 8:45 am] 

BILLING CODE P 


lotter on DSK11XQN23PROD with NOTICES1